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Myosin IXa (Myo9a) is a motor protein that is highly expressed in the brain. However,
the role of Myo9a in neurons remains unknown. Here, we investigated Myo9a
function in hippocampal synapses. In rat hippocampal neurons, Myo9a localizes to the
postsynaptic density (PSD) and binds the alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid receptor (AMPAR) GluA2 subunit. Myo9a+/− mice displayed a thicker
PSD and increased levels of PSD95 and surface AMPAR expression. Furthermore,
synaptic transmission, long-term potentiation (LTP) and cognitive functions were
impaired in Myo9a+/− mice. Together, these results support a key role for Myo9a in
controlling the molecular structure and function of hippocampal synapses.
Keywords: Myosin IXa, hippocampal synapses, PSD, AMPAR, LTP
INTRODUCTION
Myosin IXa (Myo9a, previously also called myr7) is an actin-dependent motor protein of the
unconventional myosin IX class. Myo9a is expressed in several tissues and is enriched in the brain
and testes (Chieregatti et al., 1998; Gorman et al., 1999). In the brain, Myo9a is detectable in all
regions, particularly in the hippocampus, cortex, and cerebellum, during both development and in
adulthood (Chieregatti et al., 1998).
Class IX myosins share a common structure: an N-terminal extension preceding a myosin
head, a head (motor) domain, a neck with IQ motifs that bind light chains and a C-terminal tail
containing a Rho-GTPase activating protein (RhoGAP) domain. The RhoGAP domain enables
class IX myosins to inactivate small GTPases of the Rho family (Reinhard et al., 1995).
Myo9a knockout mice develop hydrocephalus and kidney dysfunction, highlighting the
importance of Myo9a in epithelial cell morphology and diﬀerentiation (Abouhamed et al., 2009;
Thelen et al., 2015). However, the role of Myo9a in neurons has not yet been investigated.
Here, we found that Myo9a is expressed in excitatory synapses and interacts with the GluA2
subunit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) in
rat hippocampal neurons. AMPARs mediate fast excitatory transmission in the brain, and their
abundance and distribution at synapses are crucial determinants of synapse strength and plasticity
(Bredt and Nicoll, 2003; Kessels and Malinow, 2009). We therefore postulated a role for Myo9a
in the synapse and investigated its involvement in hippocampal long-term potentiation (LTP)
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and cognitive behavior. Interestingly, mice expressing reduced
levels of Myo9a (Myo9a+/− mice) displayed a thicker
postsynaptic density (PSD) and increased surface AMPAR




Myosin IXa (Myo9a) knockout mice have been described
previously in Abouhamed et al. (2009). Littermate male
Myo9a+/+ (WT) and Myo9a+/− mice were used in accordance
with national and European (86/609/EEC) guidelines.
Rats for in vitro experiments were obtained from Charles
River, Italy, and were sacriﬁced in accordance with European
Communities Council Directive 86/809/EEC. All eﬀorts were
made to minimize the number of animals used (reported in
section “Statistical Analysis”) and their suﬀering. Age of mice
used in the experiments. Mice at 4 weeks of age were used
for Golgi staining, electron microscopy (EM), biochemical,
and crosslinking assays. For electrophysiological and behavioral
studies, we used animals aged 4–6 weeks (for miniature excitatory
postsynaptic currents, mEPSCs, and paired pulse), 2–4 months
(for LTP) or 2–3 months (for behavior).
cDNA Constructs
Sequences corresponding to amino acids 2–130, 2135–2338,
and 2330–2626 from rat Myo9a (NCBI accession number:
AJ001713) were cloned into a pGEX-4T1 vector to obtain the
GST N-terminal, GST Rho-GAP, and GST C-terminal. GluA1
(from rat, NCBI accession number: X17184) and GluA2 (from
rat, NCBI accession number: M85035) in pGW1 vector were gifts
from Dr. M. Passafaro. Sequence corresponding to the GluA2
intracellular C-terminal tail (amino acids 834–883) was cloned
into a pGEX-4T1 vector to obtain the GST GluA2 C-term.
Neuronal Cultures and Biochemical
Assays
Dissociated hippocampal neurons were prepared from rat
embryos of either sex at embryonic day (E)18 as described in
Bassani et al. (2012). Neurons were plated in 6-well plates on
coverslips coated with poly-D-lysine (Sigma) at a density of
300.000/well.
Immunopurification Experiments
Immunopuriﬁcation experiments were performed as described in
Bassani et al. (2012). Brieﬂy, neurons at days in vitro (DIV)18
were lysed in 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100 (v/v), 1% saponin (w/v) and a protease inhibitor
cocktail (Sigma). The soluble extracts of neurons were loaded into
a column of resin (cyanogen bromide-Sepharose 4B resin) bound
to anti-GluA2/3 antibodies and incubated overnight at 4◦C. The
column was subsequently washed with PBS (0.1% Triton X-100).
AMPAR binding proteins were eluted with glycine (0.2 M, pH
2.2) and separated by SDS-PAGE.
Immunoprecipitation Experiments
Mouse hippocampal homogenates were prepared in buﬀer
containing 150 mM NaCl, 1 mM EDTA, 50 mM Tri-HCL,
0.5% NP-40, 0.5% Triton X-100, proteases inhibitors, pH 7.4.
Homogenates were incubated overnight at 4◦C with anti-Myo9a
antibodies (Tü 78, 10 µg/ml; Hanley et al., 2010) or rabbit
IgG (control, 10 µg/ml). Protein A agarose beads (Invitrogen)
were added, and incubation continued for 2 h. The beads were
collected via centrifugation and were washed with lysis buﬀer
(three times) and PBS plus protease inhibitors (three times), re-
suspended in sample buﬀer and boiled for 5 min for SDS-PAGE.
PSD Fractionation
The PSD fraction was prepared from rat brains and subjected to
detergent extraction as described byWyszynski et al. (1998). PSD
fractions puriﬁed by sucrose sedimentation were extracted with
Triton X-100 once (PSD I), twice (PSD II), or with Triton X-
100 followed by sarkosyl (PSD III). Samples were separated using
SDS-PAGE and visualized using immunoblotting.
Pull-Down Assays in Heterologous Cells
HEK293 cells were maintained in DMEM (Life Technologies)
supplemented with 10% FBS, 1% GlutaMAX, 1% penicillin, and
1% streptomycin. HEK293 cells at 50–70% conﬂuence (24 h
after plating onto 6-well plates) were transiently transfected
with cDNA constructs using a JetPEI Transfection Kit (Polyplus
Transfection) according to the manufacturer’s instructions. The
transfected cells were grown for 24–48 h, washed in PBS and
solubilized in lysis buﬀer (PBS, 1% Triton X-100, 1 mM EDTA,
protease inhibitor cocktail, pH 7.4). GST fusion proteins were
prepared in Escherichia coli strain BL21 and puriﬁed according to
standard procedures. The lysates were incubated overnight at 4◦C
with GST fusion protein immobilized on glutathione-Sepharose
4B beads (GE Healthcare), washed three times in lysis buﬀer
and resuspended in SDS sample buﬀer. Samples were separated
by SDS-PAGE followed by western blotting with appropriate
antibodies.
The GST GluA2 C-term was expressed in E. coli BL21 cells
and puriﬁed with the glutathione-Sepharose 4B resin. GST
GluA2 C-term bound to resin was resuspended in PBS and was
incubated with thrombin (Sigma, 10 U/mg of fusion protein)
overnight at 4◦C to release GluA2 C-termini (GluA2 C-term)
in solution. Protease cleavage was stopped with 1 mM PMSF,
and the solution containing GluA2 C-term was subsequently
incubated with glutathione Sepharose 4B-coupled GST-fusion
proteins (GST and GST C-term from Myo9a).
BS3 Crosslinking
The experiments were carried out according to Boudreau et al.
(2012). Brieﬂy, mice were sacriﬁced, and brain slices of 400 µm
thickness were cut using a vibratome and rapidly put in ice-
cold artiﬁcial Cerebral Spinal Fluid (aCSF). Cell membrane
impermeable BS3 crosslinker (PierceNet) was prepared as a
52 mM stock in 5 mM sodium citrate buﬀer pH 5. The slices were
then put into a 12-wells plate with 1 ml of ice-cold aCSF and BS3
added to a ﬁnal concentration of 2 mM. The plate was incubated
for 30 min at 4◦C with gentle agitation. Glycine was added
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to a ﬁnal concentration of 100 mM and incubated for 10 min
at 4◦C with gentle agitation to quench the reaction. The slices
were then collected and lysed with mechanical homogenization
in lysis buﬀer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1%
SDS, pH 7.4). The lysates were then loaded on acrylamide gel
and underwent standard western blotting procedures to analyze
GluA2/3, GluA1, tubulin, and transferrin receptor expression.
Western Blot and Antibodies
For the analysis of synaptic marker expression, hippocampi from
WT and Myo9a+/− mice were dissected and homogenized in
RIPA buﬀer (20 mMTris, 150 mMNaCl, 1 mM EDTA, 1%NP40,
1% Triton X-100, protease inhibitors, pH 7.5). Ten micrograms
of protein from each sample were loaded onto an acrylamide gel
for western blotting.
Primary antibodies directed against the following proteins
were used: Myo9a (Tü 76, WB 1:1000; Tü 78, IP 10 µg/ml;
Chieregatti et al., 1998; Hanley et al., 2010), Myo5a (AbCAM,
1:1000), GluA1 (Chemicon, 1:1000), GluA2 (Chemicon, 1:1000),
GluA2/3 (1:2000, gift from C. Gotti), GluK2 (Prestige, 1:1000),
Homer1 (Santa Cruz, 1:500), PSD95 (Neuromab, 1:20000),
Synaptophysin1 (SySy, 1:5000), GAPDH (Santa Cruz, 1:1000),
N-cadherin (NCAD) (AbCAM, 1:1000), PICK1 (Neuromab,
1:1000), GRIP1 (BD Transduction Laboratories, 1:2000), Tubulin
(Sigma, 1:50000), Transferrin receptor (Invitrogen, 1:1000),
VGAT (SySy, 1:1000), and VGLUT (SySy, 1:2000). The secondary
antibodies, horseradish peroxidase- (Sigma) or IR Dyes-
(LI-COR) conjugated antibodies, were used for western blots.
Samples were separated using SDS-PAGE, and western blots
then visualized with the Pierce ECL-Detection Kit or an Odyssey
Infrared Imager (LI-COR).
Golgi Staining
Mice were anesthetized by intraperitoneal injection of 10 mg/ml
avertine and transcardially perfused with 100ml of saline solution
(0.9% NaCl). After perfusion, dissected brains were plunged
in Golgi-Cox Solution (potassium dichromate 1%, mercuric
chloride 1%, and potassium chromate 0.8%) for 1 week in the
dark at room temperature. Subsequently, brains were washed
in water several times to remove the Golgi-Cox Solution and
incubated in a 30% sucrose solution for at least 2 days in the
dark at 4◦C. Coronal sections (100 µm thickness) were obtained
with a vibratome (Leica VT1000S) and collected on gelatinized
slides. After 24 h, brain slices were stained in the dark. Brieﬂy,
slices were washed twice with water and embedded for 30 min
in ammonium hydroxide. Rinsed slides were ﬁxed for 30 min
in Kodak ﬁx solution. Subsequently slices were incubated with
increasing concentrations of ethanol (50, 70, 95, and 100%) for
13 min, then a solution composed by 1/3 chloroform, 1/3 xylene,
and 1/3 ethanol for 15 min, and xylene for 15 min. Finally
slides were mounted with a coverslip using Permount mounting
medium (Fisher Scientiﬁc). Acquisition of the stained neurons
from the CA1 region of hippocampus was performed using a
Spinning Disk Confocal Microscope. Stacks were collected every
0.5 µm using 20× or 63× lens. Analysis of the dendritic spine
density was performed on 1500 µm of dendrites (63× images)
using NeuroStudio software.
Electron Microscopy
Mice were anesthetized by an intraperitoneal injection of
10 mg/ml avertine and transcardially perfused with 2.5%
glutaraldehyde and 2% paraformaldehyde in 0.15 M sodium
cacodylate buﬀer (pH 7.4). Dissected brains were post-ﬁxed
for an additional 24 h at 4◦C. Coronal sections (100 µm
thickness) were obtained with a vibratome (Leica VT1000S), and
hippocampi were manually dissected. After washing, samples
were post-ﬁxed with 2% osmium tetroxide, rinsed, stained with
1% uranyl acetate in water for 45 min, dehydrated and embedded
in epoxy resin (Electron Microscopy Science, Hatﬁeld, PA, USA)
that was baked for 48 h at 60◦C. Thin sections were obtained with
an ultramicrotome (Leica Microsystems, Austria), stained with a
saturated solution of uranyl acetate in ethanol 20% and observed
under a Philips CM10 transmission electron microscope (TEM)
(FEI, Eindhoven, Netherland). For quantitative analyses, images
were acquired at a ﬁnal magniﬁcation of 25–34000× using a
Morada CCD camera (Olympus, Munster, Germany).
Quantitative Analysis of TEM Images
Excitatory synapses in the apical dendrite layer of the
hippocampal CA1 region were identiﬁed and selected for analyses
based on the presence, in their postsynaptic terminal, of the
electron-dense PSD. We calculated the synaptic vesicle (SV)
density and density of docked SV, the area of the presynaptic
button, the density of excitatory synapses and the length and
thickness of the PSD. The average thickness of the PSD was
calculated as described in Dosemeci et al. (2001). The estimation
of the numerical density of excitatory synapses per µm3 of
hippocampus was calculated using a size-frequency stereological
method (DeFelipe et al., 1999). A total of 18 images (25000×,
20.28 µm2 each for a total of 365 µm2) were analyzed for
each genotype. Analyzed images were not from serial or nearby
sections and included exclusively apical CA1 dendrites, while
images with cell bodies, axons or non-apical dendrites were
discarded. Images were analyzed with ImageJ version 1.47 m
(NIH Image).
Electrophysiology
Hippocampal slices were prepared from WT and Myo9a+/−
male mice. Mice were anesthetized in a chamber saturated with
chloroform and then decapitated. The brain was rapidly removed
and placed in an ice-cold solution at pH 7.3, equilibrated with
95% O2 and 5% CO2 [for patch-clamp recordings: 220 mM
sucrose, 2 mM KCl, 1.3 mM NaH2PO4, 12 mM MgSO4, 0.2 mM
CaCl2, 10 mM glucose, 2.6 mM NaHCO3, 3 mM kynurenic acid;
for ﬁeld excitatory post synaptic potentials (fEPSPs) recordings:
artiﬁcial cerebrospinal ﬂuid (aCSF) containing 125 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 1 mM MgCl2, 2 mM CaCl2,
25 mM glucose, and 26 mMNaHCO3].
The cerebellum and prefrontal cortex were removed before
cutting and coronal brain slices (thickness: 300 µm for patch-
clamp recordings and 400 µm for fEPSPs) containing the
hippocampal formation were made using a vibratome (Leica
VT1000S). Immediately after the cutting procedure, slices were
incubated at 37◦C for 40 min and then at room temperature for
1 h in standard aCSF solution before recordings.
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Slices were transferred to a recording chamber perfused with
aCSF at a rate of ∼2 ml/minute at room temperature. Whole-
cell patch-clamp and fEPSPs recordings were performed using a
Multiclamp 700B ampliﬁer (Axon CNS molecular devices, USA)
and an infrared-diﬀerential interference contrast microscope.
Patchmicroelectrodes (borosilicate capillaries with a ﬁlament and
an outer diameter of 1.5 µm, Sutter Instruments) were prepared
with a four-step horizontal puller (P-1000, Sutter Instruments)
and had a resistance of 3–5 M.
Miniature excitatory postsynaptic currents (mEPSCs) were
recorded from pyramidal cells of the hippocampal CA1 region
at a holding potential of -65 mV with an internal solution
containing 126 mM K-gluconate, 4 mM NaCl, 1 mM EGTA,
1 mM MgSO4, 0.5 mM CaCl2, 3 mM ATP (magnesium salt),
0.1 mM GTP (sodium salt), 10 mM glucose and 10 mM HEPES-
KOH, pH 7.28, osmolarity adjusted to 280 mOsm.
For paired pulse experiments, two excitatory postsynaptic
currents (EPSCs) were evoked by paired stimulations of Schaﬀer’s
collaterals using a glass pipette ﬁlled with aCSF and placed
at 100/200 µm from the recorded CA1 pyramidal neuron
(interpulse interval 40 ms). The paired pulse ratio (PPR) was
computed from the average of 20 consecutive episodes of
stimulation and was calculated dividing the second response
(P2) by the ﬁrst one (P1). Access resistance was between 10
and 20 M; if it changed by >20% during the recording, the
recording was discarded.
Evoked EPSCs were recorded in the presence of bicuculline
(20 µM); mEPSCs were recorded in the presence of bicuculline
plus lidocaine (500 µM) in the aCSF.
For fEPSPs recordings, Schaﬀer-collateral ﬁber bundles were
stimulated using a glass pipette ﬁlled with aCSF and placed
at 200/300 µm from the recording electrode in the stratum
radiatum to evoke a half maximal response. After 10 min of
stable baseline (fEPSPs evoked every 20 s), LTP was induced
stimulating Schaﬀer-collaterals pathway with one train of 100
stimuli at 250 Hz according to Talani et al. (2011). Currents
and potentials were ﬁltered at 2 kHz through the ampliﬁer and
digitized at 20 kHz using Clampex 10.1 software. The analysis was
performed oﬄine with Clampﬁt 10.1 software.
Behavioral Tests
Male mice of 2–3 months of age were housed individually in
polycarbonate cages with food and water freely available through
wire lids. Cob bedding was changed weekly, and the vivariumwas
21◦C with a 12 h light cycle (lights on at 08:00 a.m.). All of the
behavioral tests were carried out between 9:00 a.m. and 1:00 p.m.
General Health Assessment
To ascertain that mice were healthy, body weight, and food intake
were monitored weekly during behavioral experiments.
Spontaneous Motor Activity
Spontaneous motor activity was evaluated in an automated
activity cage (43 cm × 43 cm × 32 cm) (Ugo Basile, Varese,
Italy) placed in a sound-attenuating room as previously described
(Ferri et al., 2004). Cumulative horizontal and vertical beam
breaks were counted for 30 min.
Visual Cliff
Visual acuity was tested in the visual cliﬀ paradigm according to
Van’t Veer et al. (2013). The apparatus consisted of a platform
with a checkered pattern positioned 1 m above the ground.
A clear piece of Plexiglas was placed on the platform and
extended 0.5 m beyond the platform edge. A checkered pattern
was also placed on the ﬂoor below the extending Plexiglas,
creating the illusion of a sudden drop-oﬀ. At the interface
between the shallow side and the deep side, there was a ridge
of aluminum (1 cm). Each mouse was placed on the aluminum
ridge and was allowed to step oﬀ to either side. Choices were
manually recorded as safe if the mouse stepped towards the
platform side (good visual acuity) and as unsafe if the mouse
chose the overhang side (poor visual acuity). Each mouse was
tested in 10 trials.
Swimming Tank Test
To monitor swimming movements, mice were trained to swim
from one end of a water-ﬁlled glass tank to a visible escape
platform at the opposite end (Perry et al., 1995). The glass tank
was 100 cm long and 6 cm wide and was ﬁlled to a depth of
20 cm with water at a temperature of 23◦C. The visible escape
platform was made from black perspex (6 cm square and 20.5 cm
high), with the top surface 0.5 cm above the water level. A vertical
black line on the side of the glass marked a horizontal distance
60 cm from the platform; this served as the start line for recording
swimming performance. During the training period, each mouse
was placed in the water at one end of the tank and within a couple
of trials, learned to swim straight to the visible escape platform
at the opposite end. After training, mice were given two trials
per day for three consecutive days, by which time they reached
stable baseline performance levels. Mice were then given two trial
tests during which mice were videotaped from both sides, and
the number of forelimb kicks, the number of hindlimb kicks, the
latency to swim the 60 cm distance and the swimming speed were
recorded using a SpeedClock iPhone application. Analysis was
based on the mean scores of the two trials for each measure.
Spatial Object Recognition
Spatial object recognition occurred in an open ﬁeld white arena
(58 cm × 50 cm × 43 cm). Two visual cues were placed on two
adjacent walls of the open ﬁeld arena according to Kenney et al.
(2011). Speciﬁcally, a black and white striped pattern was aﬃxed
to the center of the northern wall, and a black and gray checkered
pattern was placed at the center of the western wall. The animals
were ﬁrst habituated to the test apparatus for 10 min for one day.
Then, they were subjected to a familiarization trial (T1) and a
spatial object recognition trial (T2) after 120 min. During T1,
mice were placed into the open ﬁeld arena for 10min and allowed
to explore two diﬀerent objects placed in the NE andNW corners.
Objects were placed approximately 5 cm from the walls of the
open ﬁeld arena. Then the mice were returned to the home cage.
After 2 h, mice were re-exposed for 10 min to the open ﬁeld
arena where the object that was in the NW corner was moved
to the SW corner. Objects were counterbalanced across locations
and conditions. The open ﬁeld arena and all of the objects were
thoroughly wiped with 70% ethanol before and after all of the
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behavioral procedures. Care was taken to minimize the diﬀerence
between the objects in order to prevent a preference for one of
them. An experimenter blind to the mouse genotype manually
recorded the exploration time. Mice that did not explore any of
the objects for at least 30 s during T1 were excluded from the
analysis. The time spent by mice exploring each object during T1
and T2 was measured, and the discrimination index [(time spent
exploring novel object − time exploring familiar object)/(time
spent exploring novel object + time exploring familiar object)]
was calculated as described in Pitsikas et al. (2001).
T-Maze
Mice were deprived of food until they had reached 85–90% of
their free-feeding body weight. Mice were habituated to a black
wooden T-maze and trained to obtain food across the maze for
5 days (Sala et al., 2011). The T-maze had a 41 cm stem section
and a 91 cm arms section; each section was 11 cm wide and
had walls 19 cm high. In the acquisition phase, one arm was
designated as the reinforcer (Coco pops; Kellogg’s) for each of
ten daily trials. Each mouse was placed at the start of the maze
and was given a free choice to enter either arm. The number of
days to reach the criterion (80% of correct choices for 3 days) was
recorded. Each mouse that met the criterion for acquisition was
then tested using a reversal procedure in which the reinforcer arm
was changed.
Morris Water Maze
To evaluate the integrity of hippocampus-dependent memory
formation in WT and Myo9a+/− mice, the Morris water maze
paradigm according to Morris et al. (1982) was used. The water
maze was a circular tank (diameter 1.5 m) ﬁlled with water
(25 ± 0.5◦C). A platform (13.5 cm × 23 cm) was submerged
below the water’s surface in the center of the target zone.
Floating polystyrene particles were placed on the surface of the
water to hide the platform from sight. Extra maze cues (simple
geometrical shapes) and visual references (chair, table) were
present around the room to provide spatially oriented cues. Intra-
maze cues along the edge of the pool were also present. Four
points around the circumference of the maze were arbitrarily
designated as N, S, E, and W, which served as a reference for
experimenters when releasing the mice into the pool. Within each
acquisition session (i.e., four trials in a day), mice were randomly
released from each of the four points. After one day of habituation
in the maze for 60 s without the platform, acquisition training
was performed. Acquisition consisted of four trials per day for
four consecutive days and an inter-trial interval of 1 h. Once the
mouse located the hidden platform, the mouse remained on the
platform for 30 s before removal from the tank. If a mouse failed
to locate the platform within 120 s, it was guided to the platform
and remained there for 30 s before removal from the pool. On
the sixth day, the platform was removed (probe test), and the
animals were allowed to remain in the pool for 120 s. Trials were
recorded using a digital video camcorder (Canon MV900) ﬁxed
to the ceiling. An experimenter, blind to the genotype, manually
recorded the escape latency, the time spent in the quadrants of
the maze and the number of target quadrant crossings.
Statistical Analysis
Data were expressed as the mean ± SEM. An F-test was used
for variance comparison and was followed by a non-parametric
Welch’s t-test (unequal variances) or a two-tailed unpaired
Student’s t-test (equal variances). Multiple group comparisons
were performed either by one- or two-way analysis of variance
(ANOVA) followed by Tukey’s or Bonferroni’s post hoc tests. The
results were considered signiﬁcant if p< 0.05. All of the statistical
analyses were performed using Prism 6 software (GraphPad, San
Diego, CA, USA).
Number of Replicates and Number of Animals Used
Each in vitro experiment was repeated at least three times.
Primary neurons from three independent preparations were
used. The following numbers (N) of WT and Myo9a+/− mice
were analyzed: Golgi staining (Figure 2A) N = 3, 10 neurons;
EM (Figures 2B,C) N = 3, 40 presynaptic terminals, 80 PSDs;
biochemical assays (Figures 3A,B) N = 4; BS3 crosslinking
experiments (Figures 3C,D) N = 3; mEPSCs and paired pulse
recordings (Figures 4A,B) N = 8; LTP (Figure 4C) N = 3; and
behavioral tests (Figures 5 and 6) N = 5–7.
RESULTS
Myo9a Localizes to the PSD and Directly
Interacts with the AMPAR Subunit GluA2
Our study is based on the ﬁnding that Myo9a and AMPAR
are associated in the same molecular complex in hippocampal
neurons. We used anti-GluA2/3 antibodies to immunopurify
AMPARs and their interacting proteins from primary cultures
of rat hippocampal neurons (Figure 1A). As most AMPARs
in hippocampal pyramidal neurons are composed of either
GluA2-GluA1 or GluA2-GluA3 (Wenthold et al., 1996), anti-
GluA2/3 antibodies allow for the puriﬁcation of the largemajority
of AMPARs. Interestingly, we detected Myo9a among the co-
puriﬁed proteins. As expected, the GluA1 AMPAR subunit and
Myosin Va (Myo5a), which is a GluA1 C-terminus binding
partner (Correia et al., 2008), were also identiﬁed. PSD95, which
does not directly interact with AMPAR, was poorly co-puriﬁed,
and the presynaptic protein synaptophysin (SYP) was not
observed (Figure 1A), thus demonstrating the speciﬁcity of the
puriﬁed proteins. In addition to these results, the precipitation
of Myo9a with a speciﬁc antibody from mouse hippocampal
homogenates allows for the co-immunoprecipitation of GluA2/3
(Figure 1B). In neurons, AMPARs are enriched at the PSD of
dendritic spines where they mediate most of the fast excitatory
transmission (Bredt and Nicoll, 2003). The association of Myo9a
with AMPARs in biochemical assays suggests that Myo9a might
be a component of the PSD. To validate this hypothesis, we
prepared PSD fractions from the rat brain and compared the
distribution of Myo9a with that of the PSD proteins PSD95 and
AMPAR (Figure 1C). PSD95, which is the typical marker of
the PSD, is fully resistant to both Triton X-100 (PSD I and II)
and sarkosyl (PSD III) extraction. AMPAR, which is less tightly
associated with the PSD, is present in PSD fractions I and II but
is largely extracted by sarkosyl treatment (note the absence of the
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FIGURE 1 | Myosin IXa (Myo9a) localizes at excitatory synapses and binds the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
(AMPAR) GluA2 subunit. (A) Western blots of co-immunopurified proteins from DIV18 hippocampal neurons using anti-GluA2/3 antibodies or non-immune IgGs as
a control. GluA1, Myo9a, Myo5a, and reduced amounts of PSD95 were co-purified with GluA2/3, but SYP was not. (B) Co-immunoprecipitation of GluA2/3 with
Myo9a from mouse hippocampal homogenates. (C) Biochemical fractionation of Myo9a in rat brain showing the presence of Myo9a in postsynaptic density (PSD)
fractions that were extracted with Triton X-100 once (PSD I) and twice (PSD II). Myo9a was reduced following extraction with Triton X-100 followed by sarkosyl (PSD
III). (D) Schematic structure of Myo9a and its domains fused to GST. (E) Western blots of pull-down assays from HEK293 cells expressing either GluA2 (top) or
GluA1 (bottom) using GST N-term, GST Rho-GAP and GST C-term or GST as a control. Myo9a C-terminal region (GST C-term) binds GluA2 but not GluA1. Note
that a blank line was left between each sample line to avoid overflow artifacts. A small amount of overflow into the adjacent wells appears as additional narrow lines.
(F) In vitro pull-down assays of purified GluA2 C-terminus (GluA2 C-term) using Myo9a GST C-term, which indicates that Myo9a and GluA2 C-termini directly
interact. GST fusion proteins were visualized using Ponceau Red staining (underneath each immunoblot). GST fusion proteins are indicated using arrows. Small
amount of overflow into the adjacent wells appear as additional narrow lines.
GluA2/3 signal in the PSD III fraction). Myo9a is detectable in
all of the PSD fractions including PSD III, indicating a strong
association with the PSD, and it is enriched in the GluA2/3
positive fractions (PSD I and II), consistently with a Myo9a-
AMPAR association (Figure 1C).
Next, to better characterize the AMPAR-Myo9a association,
we mapped their interacting regions (Figures 1D–F). We tested
three Myo9a regions fused with the GST protein for interactions
with either GluA1 or GluA2 in transfected HEK293 cells,
namely, the N-terminal extension speciﬁc of class IX myosins
(GST N-term), the Rho-GAP domain (GST Rho-GAP) and the
C-terminus (GST C-term) (Figures 1D,E). Only the Myo9a
C-terminus was able to precipitate GluA2 (Figure 1E, top).
Interestingly GluA1was not precipitated by any of the GST fusion
proteins, indicating that Myo9a speciﬁcally binds to the AMPAR
subunit GluA2 (Figure 1E, bottom).
AMPAR subunits are characterized by diﬀerent intracellular
C-termini that bind to several proteins that are required for the
traﬃcking and synaptic expression of the receptor (Shi et al.,
2001).We therefore investigatedwhetherMyo9a binds the GluA2
C-terminal tail and whether this interaction is direct (Figure 1F).
Toward this end, we evaluated the Myo9a GST C-terminus in
a pull-down assay with the puriﬁed GluA2 C-terminus (GluA2
C-term). The Myo9a C-terminus was able to precipitate the
GluA2 C-term, which demonstrates that the C-termini of Myo9a
and GluA2 interact directly (Figure 1F).
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Altogether, these results indicate thatMyo9a is a novel binding
partner of the AMPAR subunit GluA2, and it is expressed at
the PSD.
Myo9a+/− Mice Display a Thicker PSD
and Increased PSD95 and Surface
AMPAR Levels
Because Myo9a is present in PSDs and interacts with GluA2,
we hypothesized a role of Myo9a at synapses in regulating
glutamatergic signaling and decided to investigate the eﬀect of
Myo9a deﬁciency on hippocampal synapses in vivo.
Myo9a homozygous knockout mice (Myo9a−/−) are
characterized by high lethality, develop severe hydrocephalus
within the ﬁrst 2 weeks of life and display major motor defects
(Abouhamed et al., 2009). In contrast, heterozygous mice
(Myo9a+/−) grow normally, their brain architecture is preserved
and they do not show locomotor defects (Abouhamed et al.,
2009 and data not shown). For this reason, we decided to use
Myo9a+/− in our study. Indeed Myo9a+/− mice represent a
model that is suitable for a comprehensive set of structural,
electrophysiological, and behavioral analyses.
We started by performing morphological analyses of the
excitatory synapses of the hippocampus focusing on the best-
characterized CA1 area (Figure 2). First, we evaluated the
number of dendritic spines on Golgi stained dendrites from
Myo9a+/− and WT mice. The two groups of mice had a
similar number of spines (WT 9.171 ± 0.368 vs. Myo9a+/−
9.538 ± 0.362 spines/10 µm; Figure 2A). Notably, the
stereological analysis of EM images reconﬁrmed these data (WT
1.922 ± 0.111 vs. Myo9a+/− 1.855 ± 0.145 synapses/µm3;
Figures 2B,C). Next, we assessed the morphology of pre- and
post-synaptic compartments. The area of presynaptic terminals
and the density of both total and docked SVs were the same
in both genotypes (presynaptic button: WT 0.185 ± 0.016
vs. Myo9a+/− 0.204 ± 0.019 µm2; total SV density: WT
246.3 ± 16.89 vs. Myo9a+/− 243.4 ± 20.14 vesicles/µm2; docked
SV density: WT 19.27 ± 3.79 vs. Myo9a+/− 18.18 ± 3.59
vesicles/µm2). Interestingly, Myo9a+/− mice displayed a thicker
PSD than WT mice (WT 44.65 ± 1.06 vs. Myo9a+/−
59.88 ± 1.88 nm, ∗∗∗p < 0.001), while PSD length did not
vary between genotypes (WT 0.248 ± 0.008 vs. Myo9a+/−
0.254 ± 0.007 µm; Figures 2B,C).
Because PSD size correlates with PSD protein content
(Takumi et al., 1999), we evaluated whether the thicker PSDs
of Myo9a+/− mice were associated with a higher expression
of synaptic markers in the hippocampus (Figures 3A,B). As
expected, Myo9a+/− mice were characterized by a strong
reduction of Myo9a expression (WT 1 ± 0.06 vs. Myo9a+/−
0.61 ± 0.07, ∗∗p < 0.01). Notably, reduced expression of Myo9a
was associated with a signiﬁcant increase in PSD95, which is the
major scaﬀolding protein of the PSD (WT 1± 0.15 vs.Myo9a+/−
1.33 ± 0.11, ∗p = 0.01) and of the Myo9a binding partner
GluA2 (WT 1 ± 0.09 vs. Myo9a+/− 1.28 ± 0.04, ∗p = 0.03).
In contrast, AMPAR subunits GluA2/3 and GluA1, the GluA2
interacting proteins NCAD, GRIP1, and PICK1, the kainate
receptor subunit GluK2, the scaﬀolding protein Homer1, and the
presynaptic vesicular markers VGAT and VGLUTwere unaltered
(GluA2/3: 1 ± 0.08 vs. Myo9a+/− 1.2 ± 0.05; GluA1: 1 ± 0.13
vs. Myo9a+/− 1.15 ± 0.09; GluK2: 1 ± 0.15 vs. Myo9a+/−
1.15 ± 0.14; Homer1: 1 ± 0.01 vs. Myo9a+/− 1.09 ± 0.05;
VGAT: 1 ± 0.09 vs. Myo9a+/− 0.94 ± 0.07; VGLUT1: 1 ± 0.14
vs. Myo9a+/− 1.19 ± 0.19; NCAD: 1 ± 0.21 vs. Myo9a+/−
0.84 ± 0.05; GRIP1: 1 ± 0.31 vs. Myo9a+/− 1.01 ± 0.10; PICK1:
1 ± 0.15 vs. Myo9a+/− 1.31 ± 0.21) (Figures 3A,B).
Next, we determined whether an AMPAR increase occurred
at the neuronal surface. BS3 crosslinking experiments allowed
us to quantify the surface expression of membrane proteins
and showed that Myo9a+/− mice displayed more GluA2/3-
and GluA1-containing AMPARs on the plasma membrane than
WT mice (GluA2/3: 1 ± 0.37 vs. Myo9a+/− 2.57 ± 0.27,
∗p= 0.02; GluA1: 1 ± 0.08 vs. Myo9a+/− 3.21± 0.76, ∗p= 0.04)
(Figures 3C,D).
Overall, these data indicate that Myo9a haploinsuﬃciency
did not aﬀect the density of synaptic contacts or the structure
of presynaptic terminals. In contrast, reduced levels of Myo9a
speciﬁcally altered the morphology of the PSD by increasing
PSD thickness. Concomitantly, the expression of the scaﬀolding
protein PSD95 and the GluA2 AMPAR subunit was increased in
addition to the amount of AMPARs on the plasma membrane.
Myo9a Haploinsufficiency Impairs
Hippocampal Synaptic Transmission and
LTP
Increasing AMPAR surface levels means enhancing the receptive
potential of a synapse, as more receptors will be available to
respond to the glutamate released by the presynapse. Therefore,
we investigated the spontaneous glutamatergic transmission in
CA1 pyramidal neurons of hippocampal slices by measuring
mEPSCs (Figure 4A). As expected, Myo9a+/− mice displayed
increasedmEPSC amplitude compared withWTmice, indicating
that more AMPARs were added to individual synapses (WT
11.6 ± 0.6 vs. Myo9a+/− 15.1 ± 1.2 pA, ∗p = 0.03). In contrast,
area and decay time of mEPSCswere unvaried between genotypes
(area: WT 111.8 ± 11.4 vs. Myo9a+/− 114.1 ± 11.7 pA ∗ ms;
decay time: WT 13.9 ± 1.0 vs. Myo9a+/− 12.9 ± 1.4 ms),
suggesting that there were no changes in AMPAR composition at
the surface, which is in agreement with an increase of both GluA1
and GluA2 containing AMPARs on the plasma membrane.
Notably, Myo9a+/− mice also displayed increased mEPSCs
frequency (WT 0.32 ± 0.06 vs. Myo9a+/− 0.80 ± 0.16 Hz,
∗p = 0.04, Figure 4A), which could have been due to an
increase of presynaptic neurotransmitter quanta release or
was a consequence of postsynaptic AMPARs enrichment. To
discriminate between these two possibilities, we measured paired
pulse facilitation in Myo9a+/− and WT mice (Figure 4B).
In these measurements, we observed no diﬀerences between
genotypes (WT 1.86 ± 0.13 vs. Myo9a+/− 1.52 ± 0.18) and
excluded a presynaptic eﬀect.
Our data suggested that the mEPCS frequency increase
originated from postsynaptic modiﬁcations. In particular, the
increase in frequency might by due to the presence of more
dendritic spines in Myo9a+/− mice or can be secondary
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FIGURE 2 | Myo9a+/− mice displayed a thicker PSD compared to WT mice. (A) Representative images of Golgi staining of hippocampal CA1 pyramidal
neurons (scale bar 50 µm) and apical dendrites segments (scale bar 5 µm) from Myo9a+/+ (WT) and Myo9a+/− mice (left). Dendritic spine density measurement is
shown (right). (B) Representative electron micrographs of asymmetrical synapses of CA1 stratum radiatum from WT and Myo9a+/− mice hippocampi. Arrows
indicate the PSDs (scale bar 100 nm). (C) Quantification of EM images and relative histograms. Excitatory synapse densities did not differ between genotypes. PSD
thickness is significantly increased in Myo9a+/− mice, while PSD length, the area of the presynaptic button, the density of total and docked synaptic vesicles (SV)
did not vary between genotypes.
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FIGURE 3 | Myo9a+/− mice displayed increased GluA2 and PSD95 expression levels and increased AMPAR surface content. (A,B) Immunoblots from
hippocampal homogenates from WT and Myo9a+/− mice using LI-COR technology (A) and histograms showing the quantification of synaptic markers (B).
Myo9a+/− mice, retaining approximately half of the Myo9a protein level, expressed higher levels of GluA2 and PSD95 compared with WT, but other postsynaptic
and presynaptic markers were unvaried. (C) Immunoblots from BS3 crosslinking on mouse brain slices to detect surface AMPAR pools. Both high
(surface-expressed) and predicted (intracellular) molecular weight bands were detected in tissue that was treated with the crosslinker (BS3+), whereas surface
proteins from untreated tissues (BS3–) and intracellular proteins (tubulin) yielded single bands. (D) Quantification of surface AMPAR subunits normalized to surface
transferrin receptor (TfR) is shown. In Myo9a+/− mice, surface GluA2/3 and GluA1 levels were higher than those of WT mice.
to the increased amplitude of the mEPSCs. Because the
excitatory synapse density, as evaluated by Golgi staining
and EM, was comparable between Myo9a+/− and WT mice,
we propended for the second hypothesis. We postulated
that more synapses in heterozygous mice contained a
suﬃcient amount of surface AMPARs to render their currents
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FIGURE 4 | Myo9a haploinsufficiency affected basal AMPAR transmission and impaired LTP. (A) Representative mEPSC recordings (top, left) and average
traces (2 min) (top, right) from WT and Myo9a+/− hippocampal slices in the presence of 500 µM of lidocaine and 20 µM of bicuculline. Heterozygous mice showed
a significant increase in mEPSCs amplitude and frequency, whereas currents area and decay time were unvaried (bottom). (B) Representative current traces that
were evoked by paired stimuli (left) and PPR quantification (right) indicated no differences between genotypes. (C) Quantification of field excitatory post synaptic
potentials (fEPSP) slopes before and after high frequency stimulation (HFS, left). Representative traces from WT and Myo9a+/− mice are shown (middle). The
histograms show the fEPSP slope of the last 10 min of LTP induction (right), which revealed that LTP induction is reduced in Myo9a+/− mice.
detectable. Indeed, the increased amplitude of mEPSCs allows
for the quantiﬁcation of some mEPSCs that normally fall
below the detection threshold, resulting in an increased
frequency.
Defects in the mechanisms regulating the expression and
distribution of synaptic proteins are expected to compromise
not only the basal properties of a synapse but also its plastic
remodeling in response to external stimuli. Indeed, synaptic
strengthening or weakening relies on a tight regulation of
the amount of synaptic proteins, particularly the surface pool
of AMPARs (Huganir and Nicoll, 2013). This prompted
us to investigate whether LTP was aﬀected by Myo9a
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haploinsuﬃciency. Notably, LTP induction at the CA3–
CA1 synapse was impaired in Myo9a+/− mice compared to
WT littermates (fEPSP slope, last 10 min: WT 171 ± 16.49 vs.
Myo9a+/− 119.2 ± 9.282%, ∗p = 0.02) (Figure 4C).
Together these results implicate Myo9a involvement in both
basal synaptic transmission and plasticity of the excitatory
synapses of the hippocampus.
Myo9a Haploinsufficiency Impairs
Learning and Memory
As LTP has been proposed as the biological substrate for learning
and memory (Teyler and Discenna, 1984), we tested Myo9a+/−
mice in hippocampal-dependent cognitive paradigms. We ﬁrst
found that, in contrast to Myo9a−/− littermates, Myo9a+/−
mice displayed normal spontaneous activity, as measured in an
activity cage (mean number of horizontal counts in 30 min:
WT 3230 ± 274 vs. Myo9a+/− 2870 ± 234; mean number
of vertical counts in 30 min: WT 544 ± 73 vs. Myo9a+/−
587 ± 79) (Figure 5A). Furthermore, Myo9a+/− mice showed
normal visual acuity, which was evaluated by the visual cliﬀ
paradigm (safe choices: WT 90 ± 5.7 vs. Myo9a+/− 88 ± 3.7%)
(Figure 5B), and normal swimming behavior (swimming speed:
WT 69.6 ± 4.06 vs. Myo9a+/− 81 ± 6.47 cm/s; latency to
the visible platform: WT 8.6 ± 1.85 vs. Myo9a+/− 7.2 ± 1.1
s; forelimb kicks number: WT 21.25 ± 2.95 vs. Myo9a+/−
16.75 ± 1.6; hindlimb kicks number: WT 39.8 ± 7.95 vs.
Myo9a+/− 30 ± 6.94) (Figure 5C).
Next, we performed three diﬀerent tests, namely, the spatial
object recognition, the T-maze and the Morris water maze
(Figure 6).
In the spatial object task, the hippocampus has been proposed
to combine spatial/contextual information with speciﬁc object
information that is processed by the cortex (Winters et al.,
2008). During the familiarization trial (T1), WT and Myo9a+/−
mice showed similar exploratory phenotypes as they explored
the objects for the same amount of time. However, during
the recognition trial (T2), WT mice preferentially explored the
spatially displaced object compared to the object that remained
stationary, whereas Myo9a+/− mice used the same amount of
time to explore the two objects. The equal amount of time
spent by Myo9a+/− mice to explore spatially displaced and
stationary objects indicated that they failed to discriminate
between the two objects (Discrimination index [(N–F)/(N+F)]:
WT 0.31 ± 0.03 vs. Myo9a+/− 0.122 ± 0.07, ∗p = 0.03,
Figure 6A).
To strengthen these results, we performed T-maze and water
maze tests, which rely on an intact hippocampus-dependent
spatial memory. In the T-maze task, Myo9a+/− mice required
a longer training duration to reach the criterion (80% of correct
choices for three days) during acquisition (WT 4.2 ± 0.3 vs.
FIGURE 5 | Myo9a haploinsufficiency does not affect spontaneous motor activity, visual acuity, and swimming capability. (A) WT and Myo9a+/− mice
show comparable spontaneous motor activity in terms of the number of horizontal (left) and vertical (right) movements that were evaluated in an automated activity
cage for 30 min. (B) In a visual cliff paradigm WT and Myo9a+/− mice made the same percentage of safe choices, indicating good visual acuity in both animal
groups. (C) Swimming activity of WT and Myo9a+/− was evaluated by measuring swimming speed (left), latency to the visible platform (middle) and the number of
forelimb and hindlimb kicks (right). No differences were detected between genotypes.
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FIGURE 6 | Myo9a haploinsufficiency impaired spatial learning and memory. (A) Spatial object recognition test. During the familiarization trial (T1), WT and
Myo9a+/− mice showed similar exploratory phenotypes. During the recognition trial (T2), WT mice preferentially explored the spatially displaced object over the one
that remained stationary, whereas Myo9a+/− mice used the same amount of time to explore the two (left). A two-way ANOVA revealed a significant difference in the
genotype [F (1.72) = 4.05, ∗p = 0.04] but not in the location object factor [F (3.72) = 2.29] and interaction genotype × location object [F (3.72) = 1.83]. As a result,
the discrimination index [(N–F)/(N+F)] was significantly reduced in Myo9a+/− mice when compared to WT mice (right). (B) T-maze test. WT mice performed better
during the acquisition phase when compared to Myo9a+/− mice, which required more days to reach the criterion (80% of the correct choices for three days).
Conversely, no significant difference was detected in the reversal phase. (C) Morris water maze test. Myo9a+/− mice showed an increased latency to find the
platform during the acquisition phase (top left). The Area Under the Curve (AUC) relative to the acquisition phase is shown (bottom left). During the probe test (when
the platform was removed on the 5th day), WT mice spent significantly more time in the target zone (north quadrant, N), while Myo9a+/− mice spent the same
amount of time in each quadrant (top right). Furthermore, Myo9a+/− mice crossed the north quadrant more times compared to WT littermates (bottom right).
Myo9a+/− 8.2 ± 1, t(8) = 3.83, ∗∗p = 0.005). Conversely, no
signiﬁcant diﬀerence was detected in the reversal phase (WT
5.4 ± 0.4 vs. Myo9a+/− 5.6 ± 0.6, t(8) = 0.27) (Figure 6B).
Similarly, in the Morris water maze, Myo9a+/− mice showed
an increased latency in ﬁnding the platform in the acquisition
phase (Area Under the Curve, AUC: WT 199.8 ± 20.1 vs.
Myo9a+/− 327 ± 24.2, t(8) = 4.04, ∗∗p = 0.004) (Figure 6C,
left). During the probe test Myo9a+/− mice spent the same
amount of time in each quadrant, while WT mice spent more
time in the target zone (north quadrant) (north quadrant,
N: WT 60.88 ± 10.47 vs. Myo9a+/− 10.1 ± 8.657; south
quadrant, S: WT 18.75 ± 6.718 vs. Myo9a+/− 28 ± 7.808; west
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quadrant, W: WT 11.88 ± 5.473 vs. Myo9a+/− 34.6 ± 9.607;
east quadrant, E: WT 9.17 ± 9.175 vs. Myo9a+/− 27.3 ± 5;
∗∗p < 0.01). Furthermore, Myo9a+/− mice crossed more times
the north quadrant compared to WT littermates (number of
north quadrant crossings:WT 1.5± 0.5 vs.Myo9a+/− 3.8± 0.66,
∗p = 0.03) (Figure 6C, right), suggesting that Myo9a+/− mice
did not remember the platform position and passed by the target
zone rapidly.
When considered together, these data indicate that
hippocampal-dependent cognitive processes are impaired
upon Myo9a heterozygous deletion.
DISCUSSION
In the present study, we showed that Myo9a plays a role in
hippocampal synapses and cognitive behavior. Myo9a is both
an actin-dependent motor protein and a Rho-GAP that can
inactivate RhoA (Chieregatti et al., 1998). We found that Myo9a
localizes at synapses and directly interacts with the AMPAR
subunit GluA2.
In vivo, Myo9a haploinsuﬃciency induced structural and
molecular changes in the synapses of the CA1 area of the
hippocampus. Myo9a+/− mice developed thicker PSDs and an
altered expression of postsynaptic markers. In particular, the
major scaﬀolding protein of excitatory synapses, PSD95, and
the newly identiﬁed Myo9a binding partner, GluA2, showed
increases in their level of expression.
GluA2 is detectable in the vast majority of AMPARs and
is associated with either GluA3 or GluA1 (Wenthold et al.,
1996). We found that GluA2 enrichment also occurs at
the plasma membrane, where both the GluA2/3 and GluA1
subunit levels increase. As expected, following an increase
in the level of AMPAR at the cell surface, the amplitude
and frequency of the mEPSCs were increased. Conversely, no
changes in decay time or area were observed, consistent with
an unaltered AMPAR subunit composition. Notably, we found
no alterations in the spine number, presynaptic structure and
composition, or the PPR that was used to measure presynaptic
release. Altogether, these observations strongly suggest that both
the amplitude and frequency of mEPSCs reﬂect postsynaptic
AMPAR enrichment (Stein et al., 2003) and highlight a Myo9a-
speciﬁc role in determining the molecular structure of the
PSD.
Interestingly, LTP in hippocampal slices from Myo9a+/−
mice was reduced. It is reasonable to hypothesize that LTP
is occluded in Myo9a+/− synapses, as occurred following
PSD95 overexpression, which mimics LTP (Stein et al., 2003).
Indeed, PSD thickening, PSD95 recruitment and AMPAR surface
enrichment are key features of potentiated synapses (Stein et al.,
2003).
As a likely consequence of impaired LTP, Myo9a+/− mice
demonstrated behavioral deﬁcits in hippocampus-dependent
learning and memory tasks. Notably, in the T-maze test,
Myo9a+/− mice were impaired during the acquisition phase but
not during the reversal-learning phase, which suggests that areas
beyond the hippocampus (i.e., prefrontal cortex) are involved
(Malá et al., 2015).
These observations were made in Myo9a haploinsuﬃcient
mice. Therefore, Myo9a most likely functions as a negative
regulator of PSD95 and AMPAR surface expression by virtue of
its motor function, Rho-GAP activity or both.
Myo9a down-regulation is expected to result in the up-
regulation of RhoA activity. RhoA is normally activated following
LTP induction (Murakoshi et al., 2011), and similar to PSD95
expression, constitutively active RhoA mimics and occludes LTP
by increasing the mEPSCs’ amplitude and frequency (Wang
et al., 2005). Furthermore, RhoA is required for both the early
and late phases of LTP. During the early phase, RhoA regulates
the formation of synaptic protein clusters (Wang et al., 2005;
Murakoshi et al., 2011).
Because it has been recently proposed that Myo9a has a
role in endocytosis via RhoA/ROCK signaling in kidney cells
(Thelen et al., 2015), Myo9a might have a similar function
in neurons. Indeed, the deletion of Rho-GAP OPHN1 reduces
AMPAR endocytosis as a consequence of RhoA/ROCK pathway
up-regulation (Khelfaoui et al., 2009). Myo9a might regulate
AMPAR endocytosis and possibly AMPAR traﬃcking via motor
protein activity through its binding to GluA2, which is the
subunit that drives receptor internalization (Passafaro et al.,
2001).
Even if the mechanisms remain to be elucidated, our data
support a model by which Myo9a is required for synapse
structure and function. It is tempting to speculate that Myo9a
acts as an LTP brake that prevents synapses from undergoing
uncontrolled strengthening, which is detrimental for learning
and memory.
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